Proportional Hazards Models
"Proportional Hazards Models" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Statistical models used in survival analysis that assert that the effect of the study factors on the hazard rate in the study population is multiplicative and does not change over time.
|Proportional Hazards Models
- Proportional Hazards Models
- Proportional Hazard Models
- Hazard Model, Proportional
- Hazard Models, Proportional
- Model, Proportional Hazard
- Models, Proportional Hazard
- Proportional Hazard Model
- Models, Proportional Hazards
- Hazards Model, Proportional
- Hazards Models, Proportional
- Model, Proportional Hazards
- Proportional Hazards Model
- Hazards Models
- Hazards Model
- Model, Hazards
- Models, Hazards
- Hazard Models
- Hazard Model
- Model, Hazard
- Models, Hazard
Below are MeSH descriptors whose meaning is more general than "Proportional Hazards Models".
Below are MeSH descriptors whose meaning is more specific than "Proportional Hazards Models".
This graph shows the total number of publications written about "Proportional Hazards Models" by people in this website by year, and whether "Proportional Hazards Models" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Proportional Hazards Models" by people in Profiles.
Association of Age and Overall Survival in Surgically Resected Colorectal Cancer Patients. J Surg Res. 2023 Jan; 281:321-327.
Subclinical atherosclerosis in adolescents and young adults and the risk of cardiovascular disease: The Strong Heart Family Study (SHFS). Nutr Metab Cardiovasc Dis. 2022 08; 32(8):1863-1871.
Early Local Therapy for the Primary Site in De Novo Stage IV Breast Cancer: Results of a Randomized Clinical Trial (EA2108). J Clin Oncol. 2022 03 20; 40(9):978-987.
Prognostic significance of ethnicity and age in advanced stage epithelial ovarian cancer: An NRG oncology/gynecologic oncology group study. Gynecol Oncol. 2022 02; 164(2):398-405.
Psychiatric disorders in individuals with neurofibromatosis 1 in Denmark: A nationwide register-based cohort study. Am J Med Genet A. 2021 12; 185(12):3706-3716.
CPX-351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high-risk or secondary acute myeloid leukaemia: 5-year results of a randomised, open-label, multicentre, phase 3 trial. Lancet Haematol. 2021 Jul; 8(7):e481-e491.
Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis. Gynecol Oncol. 2021 09; 162(3):532-538.
The Role of Biological Effective Dose in Predicting Obliteration After Stereotactic Radiosurgery of Cerebral Arteriovenous Malformations. Mayo Clin Proc. 2021 05; 96(5):1157-1164.
Women survive longer than men undergoing cytoreductive surgery and HIPEC for appendiceal cancer. PLoS One. 2021; 16(4):e0250726.
Future risk of diabetes among Indians with metabolic and phenotypic obesity: Results from the 10-year follow-up of the Chennai Urban Rural Epidemiology Study (CURES-158). Acta Diabetol. 2021 Aug; 58(8):1051-1058.